Nicholas L Bormann,Jesse R Burson,Emily M Burson et al.
Nicholas L Bormann et al.
Objectives: The addiction field lacks consensus terminology for individuals who utilize multiple treatments but do not enter remission. This scoping review evaluates how this concept is defined across the literature. ...
The Prevention of Smoking Relapse in Postpartum Women: A Systematic Review and Network Meta-analysis [0.03%]
产后妇女戒烟复发的预防：系统评价和网络 meta 分析
Wimonchat Tangamornsuksan,Kansak Boonpattharatthiti,Natchaya Aiumtanaporn et al.
Wimonchat Tangamornsuksan et al.
Objectives: To compare the effects of different interventions for maintaining smoking abstinence in postpartum individuals. Methods: We...
Challenging the Utility of DSM-5 Opioid Use Disorder Criteria for Diagnosing Problematic Prescription Opioid Use: Next Steps [0.03%]
挑战DSM-5阿片类药物使用障碍诊断标准用于诊断有问题的处方阿片类药物使用的实用性：下一步举措
Jane C Ballantyne,Mark D Sullivan,Andrew J Saxon
Jane C Ballantyne
When opioid therapy for chronic pain was first promulgated in the 1980s and 90s, it was thought that addiction would be rare, would occur only in high-risk individuals, and should not interfere with the continued treatment with opioids for ...
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative [0.03%]
在7天内过渡到缓释布宁片注射剂治疗阿片类药物使用障碍：一项范围叙述性研究
Jacky T P Siu,Anthony Lau,James S H Wong et al.
Jacky T P Siu et al.
Background: For patients with opioid use disorder, Sublocade (extended-release buprenorphine; Bup-XR-S) and Buvidal/Brixadi (long-acting buprenorphine; Bup-LA-B) formulations allow for less frequent dosing. Traditional in...
Tanya Calvey,Arpit Parmar,Preethy Kathiresan et al.
Tanya Calvey et al.
Objectives: Significant variations in opioid agonist treatment (OAT) practices and policy exist across different countries. We sought to understand these differences in the regulatory landscape, availability, and practice...
Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study [0.03%]
一项调查研究：物质使用或精神障碍史个体对迷幻药物治疗的态度
Sara Prostko,Alexander Wu,Samuel Maddams et al.
Sara Prostko et al.
Objectives: Psychedelics may be promising treatments for substance use disorders (SUD). This study aims to understand how individuals with alcohol use disorder (AUD), opioid use disorder (OUD), and psychiatric disorders p...
Trends and Associations in Patient Ratings Using the American Society of Addiction Medicine Criteria, 2013-2022 [0.03%]
基于美国 addiction 医学学会标准的患者评分趋势和关联（2013-2022年）
Martin T Hall,Garrett C Hardy,Jennifer S Tinman et al.
Martin T Hall et al.
Objectives: Matching individuals to the appropriate substance use treatment level is related to treatment and other health outcomes. However, only 1 study has explored whether ASAM Criteria for placement ratings differ ba...
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing [0.03%]
一种临床尿液检测高灵敏度速测甲苯磺丁脲试纸的研制与验证
Ping Wang,William Butler,Niluksha Walalawela Abeykoon et al.
Ping Wang et al.
Objectives: Xylazine has been increasingly identified in human overdose deaths. Detection of xylazine in clinical urine samples has clinical utility when treating overdoses. No screening method for xylazine has been appro...
"My Recovery and My Work Are Separate": Perceptions of MOUD Among Certified Peer Recovery Supporters [0.03%]
“我的康复和工作是分开的”：认证同伴康复支持人员对药物辅助治疗的看法
Isabelle Fox,Sydney Silverstein,Anna Murley Squibb
Isabelle Fox
Objectives: Ongoing high rates of opioid use and overdose death have prompted expansion of care options for people with substance use disorder (SUD), including medications for opioid use disorder (MOUD) and diverse forms ...
Efficacy of Clinician Education on the Americans With Disabilities Act for People With Opioid Use Disorder-A Prospective Study [0.03%]
关于阿片类药物使用障碍患者的《美国残疾人法》的医务人员教育效果——一项前瞻性研究
Anna-Maria South,Anthony A Mangino,Laura C Fanucchi et al.
Anna-Maria South et al.
Objectives: Medication for opioid use disorder (MOUD) is a standard of care for mortality-reducing treatment for people with opioid use disorder (OUD). Some health care settings have blanket policies forbidding MOUD treat...